Evidence map›Paper›PMID 38250266›Full record

ArticleFrontiers in psychiatry2023

The impact of emotional dysregulation and comorbid depressive symptoms on clinical features, brain arousal, and treatment response in adults with ADHD.

Jue Huang, Nicole Mauche, Eike Ahlers, Holger Bogatsch, Pierre Böhme, Thomas Ethofer, Andreas J Fallgatter, Jürgen Gallinat, Ulrich Hegerl, Isabella Heuser and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

Jue HuangDepartment of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
Nicole MaucheDepartment of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
Eike AhlersDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Holger BogatschClinical Trial Centre Leipzig, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Pierre BöhmeDepartment of Psychiatry Psychotherapy and Preventive Medicine, University Hospital of Bochum, Bochum, Germany.
Thomas EthoferDepartment of Biomedical Magnetic Resonance, University Hospital of Tübingen, Tübingen, Germany.
Andreas J FallgatterDepartment of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.
Jürgen GallinatDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ulrich HegerlDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Frankfurt - Goethe University, Frankfurt am Main, Germany.
Isabella HeuserDepartment of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Knut HoffmannDepartment of Psychiatry Psychotherapy and Preventive Medicine, University Hospital of Bochum, Bochum, Germany.
Sarah Kittel-SchneiderDepartment of Psychiatry, College Cork, Cork, Ireland.
Andreas ReifDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Frankfurt - Goethe University, Frankfurt am Main, Germany.
Daniel SchöttleDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stefan UntereckerDepartment of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany.
Maria StraußDepartment of Psychiatry and Psychotherapy, University of Leipzig, Leipzig, Germany.
Leipzig University · DECharité - Universitätsmedizin Berlin · DEGoethe University Frankfurt · DEUniversity Hospitals of the Ruhr-University of Bochum · DEUniversity Medical Center Hamburg-Eppendorf · DEUniversitätsklinikum Würzburg · DEUniversity Children's Hospital Tübingen · DEUniversity College Cork · IEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The role of emotional dysregulation (ED) in attention-deficit/hyperactivity disorder (ADHD) has become an important issue. This study, in which we analyzed data from a predictive pharmaco-EEG-trial, aimed to examine whether symptoms of ED in adult ADHD affect ADHD symptom severity, brain arousal regulation as measured by resting EEG, and the response to stimulant medication. Methods: ED is defined as having a sex- and age-corrected Results: No differences were found between the ED and non-ED groups in response to stimulant medication or in brain arousal regulation. In addition, there was no significant effect of ED with comorbid depressive symptoms on treatment response. There was a trend for subgroups that showed a change in brain arousal regulation associated with symptom improvement. Discussion: Our findings may support the assumption that ED may be an important feature of ADHD. The use of EEG-based brain arousal regulation as a diagnostic and predictive tool in ADHD in the presence of ED and comorbid depressive symptoms should be further investigated.

Indexed as

ADHDadultbrain arousal regulationEEGemotional dysregulationmethylphenidate

Identifiers

PMID38250266
PMCPMC10797130
OpenAlexW4390611934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.